Negative symptoms in schizophrenia—A review

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nordic Journal of Psychiatry

• Publication date

  2008-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/08039480801959307PMID 18752104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of the Negative Symptoms of Schizophrenia

  2012cited by this paper
• Psychoeducation for schizophrenia.

  2011cited by this paper
• Family intervention for schizophrenia.

  2010cited by this paper
• Clozapine versus typical neuroleptic medication for schizophrenia.

  2009cited by this paper
• Negative symptoms of schizophrenia: a problem that will not go away

  2007cited by this paper
• Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

  2007cited by this paper
• Outcome and its predictors in schizophrenia - The northern Finland 1966 birth cohort

  2007cited by this paper
• Psychosocial treatment programs for people with both severe mental illness and substance misuse.

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?

  2007cited by this paper
• Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort

  2007cited by this paper
• Supportive therapy for schizophrenia.

  2007cited by this paper
• Persistent negative symptoms in schizophrenia: an overview.

  2007cited by this paper
• The factorial structure of the schedule for the deficit syndrome in schizophrenia.

  2006cited by this paper
• Zotepine for schizophrenia.

  2006cited by this paper
• Aripiprazole for schizophrenia

  2006cited by this paper
• Affective flattening and alogia associate with the familial form of schizophrenia.

  2006cited by this paper
• A cross-sectional study of adiponectin in patients with schizophrenia

  2006cited by this paper
• The structure of negative symptoms within schizophrenia: implications for assessment.

  2006cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006influential reference
• Depression in Schizophrenia, Can it be Treated? A Review of the Evidence

  2006cited by this paper
• Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.

  2006cited by this paper
• Subdomains within the negative symptoms of schizophrenia: commentary.

  2006cited by this paper
• Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.

  2006cited by this paper
• Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.

  2005cited by this paper
• A Systematic Review of the Prevalence of Schizophrenia

  2005cited by this paper
• Cognitive–behaviour therapy for schizophrenia: a review

  2005cited by this paper
• Perphenazine for schizophrenia.

  2005cited by this paper
• Remission in schizophrenia: proposed criteria and rationale for consensus.

  2005cited by this paper
• Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up.

  2005cited by this paper
• Olanzapine for schizophrenia.

  2005cited by this paper
• Non-neuroleptic approaches to treating negative symptoms in schizophrenia

  2004cited by this paper
• Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits.

  2004cited by this paper
• Quetiapine for schizophrenia.

  2004cited by this paper
• Can Patients at Risk for Persistent Negative Symptoms Be Identified During Their First Episode of Psychosis?

  2004cited by this paper
• Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study.

  2003cited by this paper
• Chlorpromazine versus placebo for schizophrenia.

  2003cited by this paper
• Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophrenia.

  2003cited by this paper
• A meta-analysis of the efficacy of second-generation antipsychotics.

  2003cited by this paper
• The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.

  2003cited by this paper
• Negative symptoms in depressed and schizophrenic patients: how do they differ?

  2003cited by this paper
• Dementia praecox and paraphrenia

  2002cited by this paper
• Negative symptoms in first episode non‐affective psychosis

  2002cited by this paper
• A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

  2002cited by this paper
• Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials.

  2002cited by this paper
• Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission.

  2002cited by this paper
• An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia.

  2002cited by this paper
• Management of negative symptoms of schizophrenia

  2001cited by this paper
• A separate disease within the syndrome of schizophrenia.

  2001cited by this paper
• A five-year followup study of deficit and nondeficit schizophrenia.

  2001cited by this paper
• Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients.

  2001cited by this paper
• Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms.

  2001cited by this paper
• Treatment programmes for people with both severe mental illness and substance misuse.

  2000cited by this paper
• Risperidone versus typical antipsychotic medication for schizophrenia.

  2000cited by this paper
• Distress attributed to negative symptoms in schizophrenia.

  2000cited by this paper
• Assessing the Efficacy of Treatments for the Deficit Syndrome of Schizophrenia

  2000cited by this paper
• Newer atypical antipsychotic medication versus clozapine for schizophrenia.

  2000cited by this paper
• Risperidone versus other atypical antipsychotic medication for schizophrenia.

  2000cited by this paper
• Clozapine versus typical neuroleptic medication for schizophrenia.

  2000cited by this paper
• Rating Scales in Schizophrenia

  2000cited by this paper
• Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.

  2000cited by this paper
• Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study

  1999cited by this paper
• Atypical neuroleptics: a new approach in the treatment of negative symptoms

  1999cited by this paper
• Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study.

  1999cited by this paper
• Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.

  1998cited by this paper
• Drug treatment of the negative symptoms of schizophrenia.

  1998cited by this paper
• Structure of schizophrenic symptomatology and its changes over time: prospective factor‐analytical study

  1997cited by this paper
• Structure and course of positive and negative symptoms in schizophrenia.

  1995cited by this paper
• Negative Symptoms at Discharge and Outcome in Schizophrenia

  1995cited by this paper
• Schizophrenia – a Brain Disease? a Critical Review of Structural and Functional Cerebral Abnormality in the Disorder

  1995cited by this paper
• A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.

  1995cited by this paper
• Negative symptoms and the early course of schizophrenia.

  1992cited by this paper
• Assessment of enduring deficit and negative symptom subtypes in schizophrenia.

  1991cited by this paper
• Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course.

  1991cited by this paper
• Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensions.

  1990cited by this paper
• The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

  1989cited by this paper
• The Historical Evolution of the Concept of Negative Symptoms in Schizophrenia

  1989cited by this paper
• Reliability and validity of the positive and negative syndrome scale for schizophrenics.

  1988cited by this paper
• The Negative Symptoms in Chronic Schizophrenia

  1988cited by this paper
• Deficit and nondeficit forms of schizophrenia: the concept.

  1988cited by this paper
• NEGATIVE SYMPTOMATOLOGY AND SCHIZOPHRENIA: A CONCEPTUAL AND EMPIRICAL REVIEW

  1987cited by this paper
• Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up.

  1986cited by this paper
• Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study.

  1986cited by this paper
• The two-syndrome concept: origins and current status.

  1985cited by this paper
• NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION

  1985cited by this paper
• Negative and deficit symptoms in schizophrenia do respond to neuroleptics.

  1985cited by this paper
• Treatment of negative symptoms.

  1985cited by this paper

• A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics.

  2025cites this paper
• Brain Structural Alterations Underlying Mood-Related Deficits in Schizophrenia

  2025cites this paper
• Impact of loneliness and living alone on negative symptoms in severe mental illness: An electronic health record data analysis.

  2025cites this paper
• Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia.

  2025cites this paper
• Efficacy of adjunctive antidepressants in treating negative symptoms of schizophrenia: a systematic review and network meta-analysis

  2025cites this paper
• Reexamination of the relationships among neurocognition, self-defeatist beliefs, experiential negative symptoms, and social functioning in a sample of patients diagnosed with chronic schizophrenia and schizoaffective disorder

  2024cites this paper
• Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial

  2024cites this paper
• Disrupted coherence between autonomic activation and emotional expression in individuals at clinical high risk for psychosis.

  2024cites this paper
• Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial.

  2024cites this paper
• 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms

  2024cites this paper
• Integrating Subjective Recovery and Stigma Resistance in Individuals with Schizophrenia: A Narrative Review and Theoretical Integration

  2024cites this paper
• Reward anticipation-related neural activation following cued reinforcement in adults with psychotic psychopathology and biological relatives.

  2024cites this paper
• Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS)

  2024cites this paper
• Prediction of Clinical Outcomes in Psychotic Disorders Using Artificial Intelligence Methods: A Scoping Review

  2024cites this paper
• Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.

  2023cites this paper
• Effect of Family Psychological Education Program on Positive and Negative Symptoms of Schizophrenic Patients: A Randomized Controlled Trial

  2023cites this paper
• Transdiagnostic structural neuroimaging features in depression and psychosis: A systematic review.

  2023cites this paper
• Treatment effects of adjunct group music therapy in inpatients with chronic schizophrenia: a systematic review

  2023cites this paper
• Cognitive control and impulsivity in deficit schizophrenia: neuropsychological and clinical characteristics

  2023cites this paper
• Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial

  2023cites this paper
• Deconstructing emotion regulation in schizophrenia: The nature of abnormalities at the selection and implementation stages.

  2023cites this paper
• Dimensional characteristics of persistent negative symptoms in schizophrenia and their relationships with schizotypy in first-degree relatives

  2023cites this paper
• Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder

  2023cites this paper
• Caring for critically ill patients with a mental illness: A discursive paper providing an overview and case exploration of the delivery of intensive care to people with psychiatric comorbidity

  2023cites this paper
• Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up

  2023cites this paper
• A Systematic Review and Meta-Analysis of the Association Between Psychopathology and Social Functioning in Schizophrenia.

  2023cites this paper
• Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia

  2023cites this paper
• The motivation and pleasure deficits but not expressivity affects social functioning through cognitive function in male patients with schizophrenia: A structural equation model.

  2023cites this paper
• Associations between symptom and neurocognitive dimensions in clinical high risk for psychosis

  2022cites this paper
• Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation

  2022cites this paper
• Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial.

  2022cites this paper
• The Impact of Mindful Self-Compassion Intervention on Self-Esteem and Negative Symptoms of Male patients with Schizophrenia

  2022cites this paper
• Corpus Callosum Volume in Patients with First-Episode Psychosis

  2022cites this paper
• Do different adverse childhood experiences lead to specific symptoms of psychosis in adulthood? A systematic review of the current literature.

  2022cites this paper
• Medial temporal lobe and basal ganglia volume trajectories in persistent negative symptoms following a first episode of psychosis

  2022cites this paper
• Psychometric properties and diagnostic criteria of Scale for the assessment of negative symptoms (SANS) in schizophrenia

  2021cites this paper
• Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim

  2021cites this paper
• Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.

  2021cites this paper
• Adult Attachment and Personal, Social, and Symptomatic Recovery From Psychosis: Systematic Review and Meta-Analysis

  2021cites this paper
• Network Analysis of Symptom Comorbidity in Schizophrenia: Relationship to Illness Course and Brain White Matter Microstructure.

  2021cites this paper
• Glycine attenuates impairments of stimulus-evoked gamma oscillation in the ketamine model of schizophrenia

  2021cites this paper
• We are not ready to abandon the current schizophrenia construct, but should be prepared to do so.

  2021cites this paper
• Case Report: Severe Side Effects Following Treatment With First Generation Antipsychotics While Cariprazine Leads to Full Recovery

  2021cites this paper
• S2045796021000640jra 1..8

  2021influential citation
• Care needs and care consumption in psychosis: a 4-year longitudinal analysis of guideline concordant care

  2021cites this paper
• Mechanisms Underlying Motivational Dysfunction in Schizophrenia

  2021cites this paper
• Memory-Guided Saccades in Psychosis: Effects of Medication and Stimulus Location

  2021cites this paper
• The Many Faces of Negative Symptoms in Schizophrenia

  2021cites this paper
• Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia

  2021cites this paper
• Humor in Psychiatry: Lessons From Neuroscience, Psychopathology, and Treatment Research

  2021cites this paper
• EPA guidance on assessment of negative symptoms in schizophrenia

  2021cites this paper
• Aerobic exercise and cognitive functioning in schizophrenia: Results of a 1-year follow-up from a randomized controlled trial.

  2020cites this paper
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment Neuropsychiatric Disease and Treatment

  2020cites this paper
• Psychotische Störungen und Schizophrenie

  2020cites this paper
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment Neuropsychiatric Disease and Treatment

  2020cites this paper
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment Neuropsychiatric Disease and Treatment

  2020cites this paper
• 22q11.2 deletion syndrome

  2020cites this paper
• Is that schizophrenia or frontotemporal dementia? Supporting clinicians in making the right diagnosis

  2020cites this paper
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

  2020cites this paper
• Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS)

  2020cites this paper
• Nurses' Assessment of Sedation of Patients With Mental Illness: Scale Development and Validation.

  2020cites this paper
• A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

  2020cites this paper
• Developmental Influences on Symptom Expression in Antipsychotic-Naïve First-Episode Psychosis

  2020cites this paper
• Frontal white matter abnormalities reveal the pathological basis underlying negative symptoms in antipsychotic-naïve, first-episode patients with adolescent-onset schizophrenia: Evidence from multimodal brain imaging.

  2020cites this paper
• Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis

  2020cites this paper
• The behavioral and neurochemical characterization of a Drosophila dysbindin mutant supports the contribution of serotonin to schizophrenia negative symptoms.

  2020cites this paper
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment Neuropsychiatric Disease and Treatment

  2020cites this paper
• Social Values and Determinants of Cultural Fit in Quebec: The Roles of Ancestry, Linguistic Group, and Mental Health Status

  2019cites this paper
• Cognitive Behavioral Therapy for Social Activation in Recent-Onset Psychosis: Randomized Controlled Trial

  2019cites this paper
• Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?

  2019cites this paper
• The effect of mind-body and aerobic exercise on negative symptoms in schizophrenia: A meta-analysis.

  2019cites this paper
• Implications of data-driven analyses for personalized therapy in psychosis: a systematic review of cluster- and trajectory-based modelling studies

  2019cites this paper
• Effect of Risperidone with Ondansetron to Control the Negative and Depressive Symptoms in Schizophrenia

  2018cites this paper
• Health related quality of life in patients having schizophrenia negative symptoms – a systematic review

  2018cites this paper
• A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology

  2018cites this paper
• Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes

  2018cites this paper
• Schizophrenia: An Overview

  2018influential citation
• Psychosis in Emerging Adulthood: Phenomenological, Diagnostic, and Clinical Considerations

  2018cites this paper
• Identifying the “Therapy Targets” for Treating the Negative Symptoms of Psychosis Using Cognitive Behavioral Therapy

  2018influential citation
• Stressful life events and first-episode psychosis

  2017cites this paper
• The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

  2017cites this paper
• Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders

  2017cites this paper
• Early psychosis in central Vietnam: A longitudinal study of short-term functional outcomes and their predictors

  2017cites this paper
• The habenula in psychiatric disorders: More than three decades of translational investigation

  2017cites this paper
• Predicting individualized clinical measures by a generalized prediction framework and multimodal fusion of MRI data

  2017cites this paper
• Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases.

  2017cites this paper
• Clinical Expressive Symptoms and Socio-Occupational Functioning among Person with Schizophrenia

  2017cites this paper
• Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia

  2017cites this paper
• Fenotipo y genotipo de los síntomas negativos en la esquizofrenia: conceptualización, evaluación y su relación con el polimorfismo val66met del bdnf

  2017cites this paper
• Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis.

  2016cites this paper
• Social functioning in patients with a psychotic disorder and first rank symptoms.

  2016cites this paper
• Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

  2016cites this paper
• Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.

  2016cites this paper
• Sex/gender differences in the brain and cognition in schizophrenia.

  2016cites this paper
• Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia

  2016influential citation
• Could cannabidiol be used as an alternative to antipsychotics?

  2016cites this paper
• Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia

  2016cites this paper
• Improvisation socio-motrice : quels impacts sur le comportement moteur ?

  2016cites this paper
• Using early antipsychotic response to predict treatment outcome in patients with first-episode psychosis

  2016cites this paper
• The course of negative symptom in first episode psychosis and the relationship with social recovery.

  2016cites this paper